Skip to main content
. 2022 Jun 13;7(6):102. doi: 10.3390/tropicalmed7060102

Figure 6.

Figure 6

Assessment of reactivity of the developed SARS-CoV-2 S1 sandwich-based ELISA on RT-PCR-positive and -negative saliva samples using S1 mAbs as capture antibodies and nanobodies-conjugated gold nanoparticles (AuNPs-Nbs) as a detector antibodies. MERC-Cov and SARS-CoV antigens were used to test cross reactivity.